1. Home
  2. ECOR vs PFAI Comparison

ECOR vs PFAI Comparison

Compare ECOR & PFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECOR
  • PFAI
  • Stock Information
  • Founded
  • ECOR 2005
  • PFAI 2015
  • Country
  • ECOR United States
  • PFAI Canada
  • Employees
  • ECOR 62
  • PFAI N/A
  • Industry
  • ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • PFAI Farming/Seeds/Milling
  • Sector
  • ECOR Health Care
  • PFAI Consumer Staples
  • Exchange
  • ECOR Nasdaq
  • PFAI Nasdaq
  • Market Cap
  • ECOR 39.6M
  • PFAI 41.5M
  • IPO Year
  • ECOR 2018
  • PFAI 2025
  • Fundamental
  • Price
  • ECOR $4.74
  • PFAI $2.68
  • Analyst Decision
  • ECOR Strong Buy
  • PFAI
  • Analyst Count
  • ECOR 2
  • PFAI 0
  • Target Price
  • ECOR $25.50
  • PFAI N/A
  • AVG Volume (30 Days)
  • ECOR 39.5K
  • PFAI 3.3M
  • Earning Date
  • ECOR 11-05-2025
  • PFAI 11-18-2025
  • Dividend Yield
  • ECOR N/A
  • PFAI N/A
  • EPS Growth
  • ECOR N/A
  • PFAI N/A
  • EPS
  • ECOR N/A
  • PFAI 0.03
  • Revenue
  • ECOR $27,700,000.00
  • PFAI $3,289,862.00
  • Revenue This Year
  • ECOR $24.55
  • PFAI N/A
  • Revenue Next Year
  • ECOR $41.13
  • PFAI N/A
  • P/E Ratio
  • ECOR N/A
  • PFAI $89.82
  • Revenue Growth
  • ECOR 30.16
  • PFAI 56.60
  • 52 Week Low
  • ECOR $4.16
  • PFAI $1.30
  • 52 Week High
  • ECOR $19.49
  • PFAI $4.93
  • Technical
  • Relative Strength Index (RSI)
  • ECOR 42.03
  • PFAI N/A
  • Support Level
  • ECOR $4.88
  • PFAI N/A
  • Resistance Level
  • ECOR $5.17
  • PFAI N/A
  • Average True Range (ATR)
  • ECOR 0.24
  • PFAI 0.00
  • MACD
  • ECOR -0.00
  • PFAI 0.00
  • Stochastic Oscillator
  • ECOR 35.06
  • PFAI 0.00

About ECOR electroCore Inc.

electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.

About PFAI Pinnacle Food Group Limited Class A Common Shares

Pinnacle Food Group Ltd is a provider of smart farming solutions focused on vertical and hydroponic farming. The company focuses on promoting sustainable food security by developing and building customized smart farming systems for customers based on the systematic integration of technology, hardware, and software, coupled with a full range of integrated supply and technical services. It sells hydroponic growing systems and technical support services to individual households and community groups, and is developing a hydroponic growing system for urban farms. Geographically, the company generates the majority revenue from Canada, followed by New Zealand.

Share on Social Networks: